ABBV vs LLY
AbbVie vs Eli Lilly and Company — AI-powered side-by-side comparison
VS
LLY
Eli Lilly and Company
53
Watch
| Metric | ABBV | LLY |
|---|
| AI Score |
57
|
53
|
| Price |
$265.15
|
$1,162.73
|
| P/E Ratio |
74.31×
|
38.55×
|
| ROE |
-129.2%
|
77.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.5%
|
83.4%
|
| Debt / Equity |
-11.93×
|
1.62×
|
| Dividend Yield |
2.6%
|
0.6%
|
| RSI (14) |
63.7
|
52.3
|
| Beta |
0.281
|
0.502
|
| Expected Upside |
+1.4%
|
+8.3%
|
AI Committee View
Current Innellis committee reasoning for ABBV versus LLY.
ABBV leads by 4 points.
ABBV scores 57/100 (Watch) versus LLY at 53/100 (Watch).
ABBV Committee View
67% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 67.6% yoy. Risk Analyst remains cautious — high leverage (debt-to-equity 20.19) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 95.6% shows genuine earnings power backing the valuation — Value
- Dividend yield of 4.5% pays you to wait — Value
- EPS growing 67.6% YoY — Growth
Bear Case
- P/E of 73.9 is expensive by classic value standards — Value
- Price-to-book of 94.4x prices in significant intangible value — Value
- Debt-to-equity of 20.19 adds balance-sheet risk to the value case — Value
LLY Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 49.6% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 1.60) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 92.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 49.6% YoY -- genuine top-line momentum — Growth
- EPS growing 94.6% YoY — Growth
Bear Case
- P/E of 40.6 is expensive by classic value standards — Value
- Price-to-book of 38.3x prices in significant intangible value — Value
- Debt-to-equity of 1.60 adds balance-sheet risk to the value case — Value